AZN
Astrazeneca
PE ratio, current and historical analysis
- Stocks
- Healthcare
- NYSE: AZN
- PE Ratio
The current PE ratio for Astrazeneca stock as of Aug 10, 2026 is 24.02. This is calculated based on the TTM EPS of $6.74 and the stock price of $161.91 per share. The PE ratio marks a decrease of 13% from its last 4 quarters average of 27.7.
AZN PE ratio history
The average historical PE ratio of Astrazeneca for the last ten years is 79.71. The current P/E ratio of 24.02 is 70% lower than the historical average. Looking back at the last ten years, AZN's PE ratio peaked in the Dec 2021 quarter at 1,456.25, when the price was $116.5 and the EPS was $0.08. The lowest point was in the Dec 2016 quarter, when it reached 19.73 with a price of $54.64 and an EPS of $2.77.
Astrazeneca PE ratio by year
Maximum annual increase: 3,453.56% in 2021
Maximum annual decrease: -95.61% in 2022
| Year | PE ratio | PE change | Price | EPS |
|---|---|---|---|---|
| 2025 | 27.86 | -3.47% | $183.86 | $6.6 |
| 2024 | 28.86 | -17.73% | $131.04 | $4.54 |
| 2023 | 35.08 | -45.15% | $134.7 | $3.84 |
| 2022 | 63.96 | -95.61% | $135.6 | $2.12 |
| 2021 | 1,456.25 | 3,453.56% | $116.5 | $0.08 |
| 2020 | 40.98 | -57.67% | $99.98 | $2.44 |
| 2019 | 96.82 | 116.7% | $99.72 | $1.03 |
| 2018 | 44.68 | 52.6% | $75.96 | $1.7 |
| 2017 | 29.28 | 48.4% | $69.4 | $2.37 |
| 2016 | 19.73 | -35.21% | $54.64 | $2.77 |
| 2015 | 30.45 | -57.6% | $67.9 | $2.23 |
| 2014 | 71.82 | 146.8% | $70.38 | $0.98 |
| 2013 | 29.1 | 204.71% | $59.37 | $2.04 |
| 2012 | 9.55 | 50.39% | $47.27 | $4.95 |
| 2011 | 6.35 | -23.03% | $46.29 | $7.29 |
Astrazeneca PE ratio by quarter (TTM)
| Year | PE ratio | PE change | Price | EPS |
|---|---|---|---|---|
| Jun 2026 | 28.13 | -4.29% | $189.62 | $6.74 |
| Mar 2026 | 29.39 | 5.49% | $197.22 | $6.71 |
| Dec 2025 | 27.86 | 10.21% | $183.86 | $6.6 |
| Sep 2025 | 25.28 | -3.22% | $153.44 | $6.07 |
| Jun 2025 | 26.12 | -10.97% | $139.76 | $5.35 |
| Mar 2025 | 29.34 | 1.66% | $147 | $5.01 |
| Dec 2024 | 28.86 | -22.4% | $131.04 | $4.54 |
| Sep 2024 | 37.19 | -0.83% | $155.82 | $4.19 |
| Jun 2024 | 37.5 | 13.19% | $155.98 | $4.16 |
| Mar 2024 | 33.13 | -5.56% | $135.5 | $4.09 |
| Dec 2023 | 35.08 | -1.57% | $134.7 | $3.84 |
| Sep 2023 | 35.64 | -1.16% | $135.44 | $3.8 |
| Jun 2023 | 36.06 | -21.3% | $143.14 | $3.97 |
| Mar 2023 | 45.82 | -28.36% | $138.82 | $3.03 |
| Dec 2022 | 63.96 | -35.27% | $135.6 | $2.12 |
AZN Price vs fair value
AZN average PE ratio chart
What this chart measures
The Historical Valuation Regime chart shows where the stock's current valuation sits relative to its own historical valuation range over the selected lookback period.
This is a history-relative tool, not a market-relative percentile. It does not compare the stock to other companies. Instead, it compares each historical valuation reading to the stock's own past readings.
Percentile logic
The threshold lines are calculated them from the stock's real historical values using percentile interpolation. That is why some colored bands are narrow while others are wide: the band widths reflect how the stock actually traded through time.
Regime map
| Historical percentile | Regime | Chart meaning |
|---|---|---|
| 0-10 | Historically Low | Deep cheap zone |
| >10-25 | Below Average | Cheap relative to history |
| >25-75 | Average | Within the normal historical range |
| >75-90 | Above Average | Expensive relative to history |
| >90-100 | Historically High | Extreme or stretched valuation |
How to read each part
| Chart element | What it tells you |
|---|---|
| Main line | The actual historical valuation values over time for the selected metric. |
| Dashed horizontal lines | The stock's computed P10, P25, Median, P75, and P90 thresholds for the selected period. |
| Colored bands | The historical valuation zones between those thresholds. |
| Metric boxes | Current ratio, historical median, current percentile, and current regime. |
| Timeline strip | A condensed regime history showing how the stock moved between cheap, fair, and expensive states across each observation. |
Important metric definitions
Current Percentile is the percentile rank of the latest valid historical observation within the selected lookback range.
Current Regime is assigned directly from the latest observation's percentile bucket using the fixed 10 / 25 / 75 / 90 cutoffs shown above.
How to use it well
This chart is most useful for answering a narrow question: Is this stock trading high, low, or normal relative to its own history? It works best alongside growth, profitability, and forward-looking business analysis, because a stock can deserve a higher or lower regime if its business quality has changed.
Currently, AZN's PE ratio is lower than its 3, 5 and 10-year averages.
PE comparison
Astrazeneca's price to earnings (P/E) of 24.02 is lower than the Healthcare sector, the industry and its peers average. But in comparison with the Healthcare sector average of 25.25, Astrazeneca's price to earnings (P/E) is only 4.9% lower.
AZN PE vs peers
Frequently asked questions
What is Astrazeneca's PE ratio?
AZN stock has a price to earnings ratio of 24.02 as of Aug 10, 2026.
What is the 3-year average PE ratio for Astrazeneca (AZN)?
The 3-year average price to earnings ratio for AZN stock is 31.13.
What is the 5-year average PE ratio for Astrazeneca (AZN)?
The 5-year average price to earnings ratio for AZN stock is 120.42.
What is the highest PE ratio for AZN?
Over the last ten years, the quarterly PE ratio reached its highest level at 1,456.25 in the Dec 2021 quarter.
How does the current PE ratio for AZN compare to its historical average?
The current PE ratio of AZN is 70% lower than the 10-year historical average.
How is AZN's PE ratio calculated (Astrazeneca PE ratio formula)?
You can calculate the P/E ratio by dividing the most recent stock price by the trailing twelve months EPS. As of today (Aug 10, 2026), Astrazeneca's share price is $161.91. The company's earnings per share for the trailing twelve months (TTM) ending Jun 2026 is $6.74. Therefore, Astrazeneca's PE ratio for today is 24.02. PE RATIO(24.02) = STOCK PRICE($161.91) / TTM EPS($6.74)
All PE ratio stats are based on quarterly TTM periods, unless otherwise specified.